Introduction to principles of toxicology and risk assessment

Size: px
Start display at page:

Download "Introduction to principles of toxicology and risk assessment"

Transcription

1 Introduction to principles of toxicology and risk assessment SEAC Training Helsinki, 29-30/06/2009 Kimmo Louekari Unit B4, Evaluation Disclaimer: This presentation does not represent ECHA s position on the issues covered nor is it based on expert consultation within ECHA. The presentation includes an introduction to some of the basic concepts of toxicology and risk assessment. It is also a preliminary suggestion of the author on how results of risk assessment process could be used for the Human Impact Assessment under the restriction processes of REACH.

2 Introduction Paracelsus: dose makes a poison, Examples: 60 µg/day of cadmium may causes a kidney failure after long-term exposure, The current recommendations to reduce salt intake to 5 grams per day (i.e ug/day) will lower blood pressure (Cochrane reviews). Dose is usually given as mg or µg per kilogram of body weight per day

3 Introduction (2) In hazard assessment the aim is to describe the intrinsic properties (toxicity) of chemicals. Understanding the intrinsic hazardous properties can be based on animal or in vitro tests, on human data, e.g. clinical cases or epidemiological studies, and on non-testing methods to estimate how much of the chemical is necessary to produce the toxic response in human (or to obtain DNEL. i.e. a safe level) It is necessary to understand the toxic properties of a chemical to ensure that it can be used safely.

4 Distinction of hazard and risk Hazard refers to the intrinsic toxic properties of the substance/chemical Risk refers to the likelihood that there will be toxic effects in the human population Risk can not be assessed without data on the exposure of the relevant populations In REACH, toxicity data and exposure data are combined in Exposure Scenarios

5 Distinction between risk assessment (RA) and human impact assessment (HIA) some preliminary thoughts (1) The starting point of RA is that There is scientific evidence, often based on animal data, that a specific effect may occur The outcome of the RA can be A crude estimate of the likely hood or/and severity of the effect or RCR or margin of safety. e.g. 5 cases of specific cancer may occur in 1 Million exposed persons (the DMEL, level of exposure and number of exposed people are considered there) Dose response curve with respective NOAEL and LOAEL Qualitative effects sensitisation or skin corrosion may occur in a specific use scenario

6 Distinction between RA and HIA (2) In HIA we ask How many people are affected How much will the effect (cancer, skin corrosion) reduce their quality of life (NB. Reversibility of an effect) What would be the societal and economic costs of the overall effect How should the health impact be valued However, note that physical/health impact (RAC) and the following other, e.g. monetary evaluation (SEAC) should be distinct.

7 Example of exposure data - benzene Exposure scenario Duration and Inhalation Dermal Freq. of Shift average Shift average activities [mg/m3] [mg/person/da y] 3) Production of perfumes, use of benzene shift length (assumed), daily 84 (1) (90th percentile) 420 (EASE) 26 ppm 4) Distribution of gasoline, marine, road, rail; 1% benzene shift length (assumed), daily 6.8 (90th percentile) 4.2 (EASE) 2.1 ppm

8 Health effects and RC of benzene an average exposure of 1 ppm over a working lifetime of 45 years resulted in estimations which span several orders of magnitude. From cases per thousand exposed individuals to a range of cases per thousand. (Two meta-analysis based on epi data)

9 Toxic effects covered in regulatory testing and in REACH Acute toxicity, irritation/corrosion, sensitisation, repeated dose toxicity, toxicity to reproduction, genotoxicity/mutagenicity, carcinogenicity, Local/systemic effects (systemic means: distributed by circulation) Acute/chronic effects Local and acute: e.g. acids and bases on the skin or in the eye cause irritation or corrosion; Systemic and chronic: e.g. long-term exposure to benzene increases the cancer risk

10 Toxicokinetics There is no specific information requirement in REACH The available information has to be used in the CSA Covers absorption (skin, g-i- system, lungs), distribution, metabolism and excretion (urine, faeces etc.) of chemicals. supports the identification and understanding of most relevant route of exposure and bioavailability detoxification of chemicals, mainly in liver and determination of the half-life of chemicals i.e. whether a chemical should be considered accumulative of not.

11 How is toxicity identified/tested Animal testing, e.g. 90day repeated dose toxicity study where gross pathology, organs, growth, blood and urine parameters etc are studies. Organ toxicity and/ or general systemic toxicity can often be observed In vitro testing: for skin and eye irritation/corrosion and genotoxicity testing, possible for some other endpoint in future Human evidence: comes mainly from clinical reports, poisoning cases, epidemiological data, or from worker health surveys QSAR, read-across and categories: QSAR modelling tools better suited for some toxic endpoints (e.g. mutagenicity) than for the others,

12 Animal (in vivo) studies Mostly used for effect assessment for human health; More or less good models for humans; Different species and strains; EU Annex V Guidance, OECD guidance,

13 In vitro studies Results from in vitro test may fully or partly replace an in vivo test if: - validated according to internationally agreed validation principles, - results adequate for C&L, RA. The use of results from in vitro methods that have not yet been scientifically validated ( suitable studies ) depends on whether such study indicates certain dangerous property and on the potential risk identified. In vitro studies Genotoxicity/Cytotoxicity Dermal absorption Irritation (skin eye), phototoxicity Cellular metabolism/mechanism of action Macromolecular binding Sperm motility/embryo culture

14 Human data Analytical epidemiological studies Relationship between human exposure and effects: biological effects marker, early signs of chronic effects, disease occurrence or mortality case control, cohort, cross sectional studies Descriptive epidemiological studies (examine differences in disease rates in relation to differences in temporal and environmental conditions ) Case reports (particular effects after exposure; often single exposure; misuse of the substance) Controlled studies in human volunteers Meta-analysis Ethical considerations!

15 (Q)SARs Results obtained from valid (Q)SARs may indicate the presence or absence of a certain dangerous property. Results of (Q)SARs may be used instead of testing when the conditions in Annex XI (1.3) are met: - Established scientific validity - Substance within the applicability domain - Results adequate for C&L and RA - Adequate and reliable documentation Not well developed/validated in relation to mammalian toxicity (skin sensitization, mutagenicity, skin irritation/corrosion); Well developed (Q)SARs for phys-chem properties relevant for effect assessment for human health

16 There are many types of effect data Read Across (Q)SARs Waiving: technical exposure Endpoint Information: Annexes V-IX TESTING Last resort In-vitro Existing information

17 Effect Assessment (1) Assessment of the inherent properties potential to cause harm Objectives: Determine Classification and Labelling Derive levels of exposure to the substance above which humans should not be exposed Derived Noeffect Levels (DNELs)

18 Effect assessment (2) Involves Selection of the key study, for each endpoint to be evaluated Assessment of the human/biological relevance and severity of the effects observe e.g. reversible/irreversible, adaptive or harmful/adverse consideration of the toxicokinetics Evaluation of the dose-response Is done by industry, and checked by the Agency for 5% of the dossiers within the compliance check

19 Dose response relationship If an experiment is well done, there should be a relation between dose and the effect/response, i.e. with increased dose/concentration the effect increases, i.e. more of the exposure animals have the effects or the effect becomes more severe If dose response relationship can not be seen, it may be the it was a chance finding or artifact, then the study data usually can not be alone used for risk assessment

20 Reversibility of the effect Normally, reversible effect are regarded as less severe than irreversible ones. In some tests, there is a follow-up period to observe whether the animal recover in time, e.g. irritation/corrosion studies and acute toxicity studies (e.g. 7 days). Reversibility depends e.g. on the regenerative and repair capacity of cells and sub-cellular structures; e.g. epithelial cell of gastro intestinal tract have high regenerative capacity, whereas nerve cells of adults have completely lost this capacity. Covalent binding of a genotoxic substance with DNA, cancer and damage of central nervous system are considered irreversible

21 DNEL=Derived No Effect Level Is calculated by dividing the NOAEL/dose descriptor by the assessment factor For example if NOAEL from a reproduction toxicity study (reduced fertility/sperm count) would be 150 mg/kg (of body weight of experimental animal) and assessment factor would be 1000, DNEL is 150 µg/kg/b.w (for human).

22 DNEL (2) DNEL is needed fro risk characterization (RC) In RC, DNEL is directly compared with the exposure level of the relevant human population For example if workers exposure in cleaning work is 100 µg/kg (normally derived from inhalation exposure Risk characterization ratio would be 100/150, which is 0.66, i.e below 1 Thus, it could be concluded and the use of the substance in that scenario is safe

23 Assessment factors in DNEL Aim to cover Interspecies (between animal and human) and intraspecies (among humans) Severity of the effect Sensitivity of the human (sub-)populations (e.g. children, pregnant women) Quality of the data Extrapolation from shorter test to chronic exposure A specific DNEL might be named e.g. as worker-dnel long-term for dermal route

24 Basic assessment factors Interspecies variation Intraspecies variation kinetics dynamics kinetics dynamics

25 Implications to the HIA and SEA When RCR is close to 1 and especially when it is above it, there may be health consequences Uncertainties in the risk assessment and especially the size of the sub-population exposure should then be analysed carefully This may have been done by the applicant of authorisation already or it may require more close examination by RAC and SEAC Combination of 1. CMR effect, 2. high RCR and 3. large size of exposure population (and/or wide spread uses) would be the worst scenario

26 NOAEL=No Observed Adverse Effect Level May be obtained from any toxicity study where different dose levels have been applied E.g. Dose levels of 10, 150, 500 mg/kg may have been used in a repro study In case 500 mg/kg caused decreased fertility in the reproduction toxicity study then 150 mg/kg would be NOAEL The effect is supposed to be adverse; e.g. irreversible organ damage, skin corrosion or cancer are adverse effects, whereas mild irritation of skin or transient change of liver enzyme levels are considered less adverse.

27 NOAEL (2) NOAEL normally is not obtained from irritation/corrosion, mutagenicity or sensitisation study In reproduction toxicity study and repeated dose toxicity study, when there is an adverse effect it should always be possible to obtain a NOAEL or LOAEL

28 DMEL Especially genotoxic carcinogens are considered to have no effect threshold; thus NOAEL can not be set. This implies that exposure needs to be minimised leading to very strict controls and setting of DMEL, Derived Minimal Effect Level whereas non-genotoxic carcinogenicity is thought to be a threshold effect and thus, DNEL can be obtained

29 DMEL (2) Starting point of DMEL derivation can be e.g. T25 which is a dose that causes the tumour incidence in exposure am anal to increase by 25% and compared to the control animals To obtain DMEL, T25 is divided by every high assessment factor

30 DMEL (3) The philosophy behind high assessment factor is the linear extrapolation and acceptable of small statistical risk, i.e. if the number of exposed people is not tens or hundreds of millions, the risk might be only statistical. i.e. there would be no cancer cases associated with the exposure to the chemical

31 Risk Assessment Process Exposure assessment Data evaluation Data set Effects assessment Operational conditions TGD Toxicity data Measurements modeling Exposure estimate Risk characterization RCR IUCLID5 EUSES, ECETOC TRA Assessment factors DNEL

32 Information requirements (1) Depend on the amount of substance manufactured or imported. Information submitted to ECHA in registration should enable classification and labeling as well as risk assessment

33 Information requirements (2) For example, at the 1-10 t/a level, data on irritation/corrosion, sensitisation, mutagenicity (only the Ames test) and acute oral toxicity At higher levels, the information requirement for repeated dose toxicity and on reproduction toxicity are set At the highest tonnage, i.e. above 1000 t/a, data which enables full assessment of repeated dose toxicity (up to chronic toxicity), reproduction toxicity (up to two generation reproduction toxicity test) and mutagenicity has to be provided.

34 An example of qualitative grading of the risk level, based on R-phrases and level of exposure BS 8800 Level of exposure based on a questionnaire Hazard categories of the health effects (R-phrases) slight harm Irritation or other transient mild effect, e.g. R20, R21, R36 moderate harm, Irreversible effects are possible, skin sensitisation, skin or eye corrosion, e.g. R34, R43, R48 extreme harm asthma, intoxications, carcinogenesis e.g. R35, R41, R42, Low Low risk Low risk Medium risk Moderate Low risk Medium risk High risk High Medium risk High risk High risk

35 Restriction process When a MS CA justifies the restriction proposal, it may need to, depending on the specific case Proceed from the RA to HIA, in order to point out the public health consequences of the current non-restricted use(s) and show the benefits of the restriction Revise the toxicological evaluation (e.g. DNEL) or the exposure assessment to demonstrate the there is an uncontrolled or unmanaged risk, associated with specific uses/products and thereby with specific Exposure Scenario(s) Provide an estimate of the size of the sub-population exposed to the substance. For that purpose, information of the market share/penetration, use pattern may be relevant

36 Uncertainties Assessment factors are partly regulatory assumptions rather that scientific, AFs may be over- or underprotective Especially interspecies differences can be substantial, e.g. different/lacking mechanisms, Only those health effects can be observed for with there are testing/information requirement; low tonnage testing is very crude There are e.g. immunotoxic and developmental neurotoxic effects which may go unidentified even at higher tonnage Most of in vitro methods and QSAR tools are not yet robust enough.

How to estimate the health impact for restriction process with a special focus on estimation of the number of exposed people

How to estimate the health impact for restriction process with a special focus on estimation of the number of exposed people How to estimate the health impact for restriction process with a special focus on estimation of the number of exposed people SEAC Training Helsinki, 29-30/06/2009 Kimmo Louekari Unit B4, Evaluation Disclaimer:

More information

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP)

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP) 1 (10) Helsinki, 09 September 2016 RAC/38/2016/09 rev 1 Final APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP) Background At the 22 nd meeting of the Committee for

More information

TNsG on Annex I Inclusion Revision of Chapter 4.1: Quantitative Human Health Risk Characterisation

TNsG on Annex I Inclusion Revision of Chapter 4.1: Quantitative Human Health Risk Characterisation TNsG on Annex I Inclusion Revision of Chapter 4.1: Quantitative Human Health Risk Characterisation These Technical Notes for Guidance were adopted during the 34 th meeting of representatives of Members

More information

Read-across illustrative example

Read-across illustrative example Part 2 Example 1 Analogue approach: similarity based on breakdown products Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland Tel. +58 9 686180 Fax +58 9 68618210 echa.europa.eu 2 Example 1 DISCLAIMER

More information

TRIS (NONYLPHENYL) PHOSPHITE SUMMARY RISK ASSESSMENT REPORT

TRIS (NONYLPHENYL) PHOSPHITE SUMMARY RISK ASSESSMENT REPORT TRIS (NONYLPHENYL) PHOSPHITE CAS-No.: 26523-78-4 EINECS-No.: 247-759-6 SUMMARY RISK ASSESSMENT REPORT Final report, 2007 France Rapporteur for the risk assessment of tris(nonylphenyl) phosphite is the

More information

Official Journal of the European Union

Official Journal of the European Union 1.6.2016 L 144/27 COMMISSION REGULATION (EU) 2016/863 of 31 May 2016 amending Annexes VII and VIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation,

More information

Part 2. Chemical and physical aspects

Part 2. Chemical and physical aspects Part 2. Chemical and physical aspects 12. Chemical and physical aspects: introduction 12.1 Background information used The assessment of the toxicity of drinking-water contaminants has been made on the

More information

How to bring your registration dossier in compliance with REACH Tips and Hints - Part 5

How to bring your registration dossier in compliance with REACH Tips and Hints - Part 5 How to bring your registration dossier in compliance with REACH Tips and Hints - Part 5 Higher Tier Human Health II Norbert Bornatowicz Kimmo Louekari Ulrike Reuter Content of the presentation Endpoints

More information

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

Official Journal of the European Union. (Non-legislative acts) REGULATIONS 21.2.2015 L 50/1 II (Non-legislative acts) REGULATIONS COMMISSION REGULATION (EU) 2015/282 of 20 February 2015 amending Annexes VIII, IX and X to Regulation (EC) No 1907/2006 of the European Parliament

More information

Developmental neurotoxicity & REACH

Developmental neurotoxicity & REACH Developmental neurotoxicity & REACH Hannele Huuskonen DNT WS 2016 REACH Article 1 The purpose of this Regulation is to ensure a high level of protection of human health and the environment, including the

More information

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELS FOR BBP

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELS FOR BBP Helsinki, 2 September 20 RAC/26/20/07 Rev. (Agreed at RAC-26) APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELS FOR BBP Background At the 22 nd meeting of the Committee for Risk Assessment (RAC)

More information

Justification for the selection of a substance for CoRAP inclusion

Justification for the selection of a substance for CoRAP inclusion Justification for the selection of a substance for CoRAP inclusion Substance Name (Public Name): Chemical Group: Aluminium chloride inorganic mono constituent substance EC Number: 231-208-1 CAS Number:

More information

1,1 - iminodipropan-2-ol

1,1 - iminodipropan-2-ol Possibility for MSCA Logo] SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for 1,1 - iminodipropan-2-ol EC No 203-820-9 CAS No 110-97-4 Evaluating Member State(s): Czech Republic

More information

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48. SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Butanone oxime EC No 202-496-6 CAS No 96-29-7 Evaluating Member State(s): Germany Dated: 18 March 2014 Evaluating Member State

More information

Dose and Response for Chemicals

Dose and Response for Chemicals Dose and Response for Chemicals 5 5 DOSE AND RESPONSE FOR CHEMICALS All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy. Paracelsus, 16th

More information

Step by Step Approach for GPS Risk Assessment

Step by Step Approach for GPS Risk Assessment Step by Step Approach for GPS Risk Assessment 1) Tier Categorization and Prioritization 2) Hazard Characterization By Mr. Krittanon Yuen-ying (Product Regulatory) Dow Chemical Thailand Limited Email: krittanon.yuen-ying@dow.com

More information

ANNEX IX STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 100 TONNES OR MORE ( 1 )

ANNEX IX STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 100 TONNES OR MORE ( 1 ) 29.5.2007 L 136/111 ANNEX IX REQUIREMTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 100 TONNES OR MORE ( 1 ) At the level of this Annex, the registrant must submit a proposal and a time schedule

More information

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP)

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP) EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER

More information

APPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS

APPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS 1 (7) Helsinki, 04 December 2013 RAC/27/2013/07 Rev. 1 (Agreed at RAC-27) APPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS

More information

Justification for the selection of a candidate CoRAP substance UPDATE

Justification for the selection of a candidate CoRAP substance UPDATE Justification for the selection of a candidate CoRAP substance UPDATE Substance Name (Public Name): Chemical Group: Tetrapropylenebenzene Branched alkylbenzenes EC Number: 246-772-4 CAS Number: 25265-78-5

More information

Webinar: use of alternative methods to animal testing in your REACH registration

Webinar: use of alternative methods to animal testing in your REACH registration Webinar: use of alternative methods to animal testing in your REACH registration Using alternative methods to meet your information requirements 22 September 2016 Kimmo Louekari Evaluation Unit European

More information

Opinion on Voluntary Risk Assessment Report on lead and lead compounds. Human Health Part

Opinion on Voluntary Risk Assessment Report on lead and lead compounds. Human Health Part Scientific Committee on Health and Environmental Risks SCHER Opinion on Voluntary Risk Assessment Report on lead and lead compounds Human Health Part CAS No: 7439-92-1, 1317-36-8, 1314-41-6, 69011-06-9,

More information

Human health effects of antimony an update

Human health effects of antimony an update Human health effects of antimony an update Dr. R.V. Battersby EBRC Consulting GmbH Karine Van de Velde i2a Secretary General Raffaelstr. 4 30177 Hannover Germany Public perception of HH effects of antimony

More information

TARGETED RISK ASSESSMENT REPORT ON SODIUM HYDROXIDE (NAOH) HUMAN HEALTH PART. CAS No.: ; EINECS No.:

TARGETED RISK ASSESSMENT REPORT ON SODIUM HYDROXIDE (NAOH) HUMAN HEALTH PART. CAS No.: ; EINECS No.: TARGETED RISK ASSESSMENT REPORT ON SODIUM HYDROXIDE (NAOH) HUMAN HEALTH PART CAS No.: 1310-73-2; EINECS No.: 215-185-5 Opinion adopted by the SCHER during the 14 th plenary of 30 November 2006 ACKNOWLEDGEMENTS

More information

RISK MANAGEMENT OPTION ANALYSIS CONCLUSION DOCUMENT

RISK MANAGEMENT OPTION ANALYSIS CONCLUSION DOCUMENT RISK MANAGEMENT OPTION ANALYSIS CONCLUSION DOCUMENT for Substance name: 2,4,6-trimethyl-2,4,6-tris(3,3,3- trifluoropropyl)cyclotrisiloxane, F-D3 EC number: 219-154-7 CAS number: 2374-14-3 Member State(s):

More information

Methodologies for development of human health criteria and values for the lake Erie drainage basin.

Methodologies for development of human health criteria and values for the lake Erie drainage basin. 3745-1-42 Methodologies for development of human health criteria and values for the lake Erie drainage basin. [Comment: For dates of non-regulatory government publications, publications of recognized organizations

More information

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48. SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Buta-1,3-diene EC No 203-450-8 CAS No 106-99-0 Evaluating Member State(s): Germany 22 October 2015 Evaluating Member State Competent

More information

CHEMICAL SAFETY REPORT EXECUTIVE SUMMARY

CHEMICAL SAFETY REPORT EXECUTIVE SUMMARY CHEMICAL SAFETY REPORT EXECUTIVE SUMMARY Substance Name: Potassium methylsilanetriolate EC Number: 250-807-9 CAS Number: 31795-24-1 Registrant s identity: Wacker Chemie AG, Germany 1 CONTENTS 1 IDENTIFIED

More information

Ecopa REACH Animal Use Calculator

Ecopa REACH Animal Use Calculator european consensus platform on 3R-alternatives Ecopa REACH Animal Use Calculator Karsten Müller & Simon Webb Apply the Same Principle as Today... Data Collection Classification, Labelling and SDS Risk

More information

Risk Assessment Report on styrene. Human Health Part

Risk Assessment Report on styrene. Human Health Part Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on styrene Human Health Part CAS No.: 100-42-6 EINECS no.: 202-851-5 SCHER adopted this opinion at its 23 rd plenary

More information

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE VICH GL54 (SAFETY) ARfD November 2016 For Implementation at Step 7 STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE (ARfD)

More information

5.15 HEXYTHIAZOX (176)

5.15 HEXYTHIAZOX (176) Hexythiazox 225 5.15 HEXYTHIAZOX (176) TOXICOLOGY Hexythiazox is the ISO approved name for (trans-5-(4-chlorophenyl)-n-cyclohexyl-4-methyl-2-oxo- 3-thiazolidine-carboxamide (CAS No. 78587-05-0). Hexythiazox

More information

Committee for Risk Assessment (RAC)

Committee for Risk Assessment (RAC) Committee for Risk Assessment (RAC) Opinion on the ECHA s draft review report on Evaluation of new scientific evidence concerning DINP and DIDP in relation to entry 52 of Annex XVII to Regulation (EC)

More information

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *)

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *) DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *) Guideline Title Dose Selection for Carcinogenicity Studies of Pharmaceuticals *) Legislative basis Directive 75/318/EEC as amended Date

More information

Zinc: Issues and Update. Craig Boreiko, Ph.D. Ottawa May 2008

Zinc: Issues and Update. Craig Boreiko, Ph.D. Ottawa May 2008 Zinc: Issues and Update Craig Boreiko, Ph.D. Ottawa May 2008 Topics Basics of zinc deficiency and essentiality Nutrition vs Toxicology Effects of elevated zinc intake Comparison of risk assessments Concluding

More information

HUMAN HEALTH RISK ASSESSMENT FOR METALLIC CHROMIUM AND TRIVALENT CHROMIUM IN ACCORDANCE WITH EUROPEAN UNION LEGISLATION

HUMAN HEALTH RISK ASSESSMENT FOR METALLIC CHROMIUM AND TRIVALENT CHROMIUM IN ACCORDANCE WITH EUROPEAN UNION LEGISLATION HUMAN HEALTH RISK ASSESSMENT FOR METALLIC CHROMIUM AND TRIVALENT CHROMIUM IN ACCORDANCE WITH EUROPEAN UNION LEGISLATION M. Luotamo and V. Riihimäki Unit of Toxicological Risk Assessment, FIOH, Finnish

More information

Risk Assessment of Chemicals in Foods- WHO Principles and Methods

Risk Assessment of Chemicals in Foods- WHO Principles and Methods Risk Assessment of Chemicals in Foods- WHO Principles and Methods Presented by Dr Debabrata Kanungo DK 31-07-2018 Seminar on Food Additives: A Global Perspect on Safety Evaluation and Use July 19-20, 2018

More information

FAQs on bisphenol A in consumer products

FAQs on bisphenol A in consumer products FAQs on bisphenol A in consumer products Updated BfR FAQ, 19 February 2015 The substance bisphenol A is contained in polycarbonate products such as food and drink containers and bottles. Bisphenol A is

More information

Substance Evaluation Conclusion Document EC No SUBSTANCE EVALUATION CONCLUSION. as required by REACH Article 48 and EVALUATION REPORT.

Substance Evaluation Conclusion Document EC No SUBSTANCE EVALUATION CONCLUSION. as required by REACH Article 48 and EVALUATION REPORT. Substance Evaluation Conclusion Document EC No 203-253-7 SUBSTANCE EVALUATION CONCLUSION as required by REACH Article 48 and EVALUATION REPORT for 4-Methylanisole EC No 203-253-7 CAS No 104-93-8 Evaluating

More information

SCIENTIFIC COMMITTEE ON TOXICITY, ECOTOXICITY AND THE ENVIRONMENT (CSTEE) Opinion on the results of the Risk Assessment of:

SCIENTIFIC COMMITTEE ON TOXICITY, ECOTOXICITY AND THE ENVIRONMENT (CSTEE) Opinion on the results of the Risk Assessment of: EUROPEAN COMMISSION DIRECTORATE-GENERAL HEALTH AND CONSUMER PROTECTION Directorate C - Scientific Opinions Unit C2 Management of Scientific Committees; scientific co-operation and networks Scientific Committee

More information

Risk Assessment Report on Hexachlorocyclopentadiene (HCCP) Human Health Part. CAS No.: EINECS No.:

Risk Assessment Report on Hexachlorocyclopentadiene (HCCP) Human Health Part. CAS No.: EINECS No.: Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on Hexachlorocyclopentadiene (HCCP) Human Health Part CAS No.: 77-47-4 EINECS No.: 201-029-3 The SCHER adopted this opinion

More information

Robert G. Sussman, Ph.D., DABT Managing Principal, Eastern Operations. SafeBridge Consultants, Inc. Mountain View, CA New York, NY Liverpool, UK

Robert G. Sussman, Ph.D., DABT Managing Principal, Eastern Operations. SafeBridge Consultants, Inc. Mountain View, CA New York, NY Liverpool, UK Robert G. Sussman, Ph.D., DABT Managing Principal, Eastern Operations SafeBridge Consultants, Inc. Mountain View, CA New York, NY Liverpool, UK Paracelsus (1493 1541) All substances are poisons; there

More information

Committee for Risk Assessment RAC. Opinion on new scientific evidence on the use of boric acid and borates in photographic applications by consumers

Committee for Risk Assessment RAC. Opinion on new scientific evidence on the use of boric acid and borates in photographic applications by consumers Committee for Risk Assessment RAC Opinion on new scientific evidence on the use of boric acid and borates in photographic applications by consumers ECHA/RAC/A77-O-0000001273-82-05/F Adopted 29 April 2010

More information

Maximum Residue Limits

Maximum Residue Limits Maximum Residue Limits a scientific approach to ensure consumer safety ànd (food) animal health Prof Dr Erik De Ridder 1 Residues & safety: ADME Metabolism Distribution Excretion Administration Absorption

More information

Rationale for TEL, WES and NOAEC values for ethanedinitrile, Draft 1

Rationale for TEL, WES and NOAEC values for ethanedinitrile, Draft 1 Rationale for TEL, WES and NOAEC values for ethanedinitrile, Draft 1 Prepared by Adam Jonas, Ph.D. A) Summary of relevant chronic studies 1) Ethanedinitrile: In Lewis et al. 1984 study, they exposed animals,

More information

5.3 AZINPHOS METHYL (002)

5.3 AZINPHOS METHYL (002) 5.3 AZINPHOS METHYL (002) TOXICOLOGY Azinphos-methyl is the ISO approved common name for S-3,4-dihydro-4-oxo-1,2,3-benzotriazin-3- ylmethyl O,O-dimethyl phosphorodithioate (IUPAC) or O,O-dimethyl S-[(4-oxo-1,2,3-benzotriazin-

More information

Justification for the selection of a candidate CoRAP substance

Justification for the selection of a candidate CoRAP substance Justification for the selection of a candidate CoRAP substance Substance Name (Public Name): Diethyl phthalate Chemical Group: EC Number: 201-550-6 CAS Number: 84-66-2 Submitted by: Germany/Portugal Published:

More information

The Inhalation DNEL- Challenge

The Inhalation DNEL- Challenge The Inhalation DNEL- Challenge Jürgen Pauluhn Rome, October 1, 2010 Wuppertal, Germany First Step of Risk Characterization: Reference Concentration for Workers DNEL = derived no effect level - the level

More information

Justification Document for the Selection of a CoRAP Substance

Justification Document for the Selection of a CoRAP Substance Justification Document for the Selection of a CoRAP Substance Group Name: Iron complexes with N,N'-1,2- ethanediylbis{n-[(2- hydroxyphenyl)methyl]glycine} derivatives EC Numbers: 938-828-8, 283-041-9,

More information

Toxicological tool. Sarah O Meara, PhD, MSc PharmMed Non-clinical Assessor. GMP Conference 12 th November 2014

Toxicological tool. Sarah O Meara, PhD, MSc PharmMed Non-clinical Assessor. GMP Conference 12 th November 2014 Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities Toxicological tool Sarah O Meara, PhD, MSc PharmMed

More information

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48. SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for 2-AMINOETHANOL EC No 205-483-3 CAS No 141-43-5 Evaluating Member State(s): UK Dated: September 2016 Evaluating Member State

More information

CATEGORY 4 - Rosin adduct esters UVCB CATEGORY JUSTIFICATION DOCUMENT

CATEGORY 4 - Rosin adduct esters UVCB CATEGORY JUSTIFICATION DOCUMENT CATEGORY 4 - Rosin adduct esters UVCB CATEGORY JUSTIFICATION DOCUMENT 1.0 CATEGORY DEFINITION AND ITS MEMBERS This document describes the Rosin adduct esters category and its members as per ECHA guidance

More information

Annex to a news release

Annex to a news release Annex to ECHA News 1 (5) 15 June 2018 Annex to a news release Helsinki, 15 June 2018 SEAC adopted one restriction proposal Lead and its compounds in shot SEAC adopted its final opinion, in support of the

More information

Considerations in Toxicology Study Design and Interpretation: An Overview Gradient Corporation: Lewis, AS; Beyer, LA; Langlois, CJ; Yu, CJ; Wait, AD

Considerations in Toxicology Study Design and Interpretation: An Overview Gradient Corporation: Lewis, AS; Beyer, LA; Langlois, CJ; Yu, CJ; Wait, AD Considerations in Toxicology Study Design and Interpretation: An Overview Gradient Corporation: Lewis, AS; Beyer, LA; Langlois, CJ; Yu, CJ; Wait, AD Introduction The use of animal data to evaluate the

More information

Risk Assessment Report on sodium hypochlorite Human Health Part. CAS No.: EINECS No

Risk Assessment Report on sodium hypochlorite Human Health Part. CAS No.: EINECS No Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on sodium hypochlorite Human Health Part CAS No.: 7681-52-9 EINECS No. 231-668-3 The SCHER adopted this opinion at its

More information

Justification for the selection of a candidate CoRAP substance

Justification for the selection of a candidate CoRAP substance Justification for the selection of a candidate CoRAP substance Substance Name (Public Name): Chemical Group: N,N-dicyclohexylbenzothiazole-2-sulphenamide Benzothiazole EC Number: 225-625-8 CAS Number:

More information

Dichlorvos DICHLORVOS (025)

Dichlorvos DICHLORVOS (025) Dichlorvos 63 5.7 DICHLORVOS (025) TOXICOLOGY Dichlorvos is the International Organization for Standardization (ISO) approved common name for 2,2-dichlorovinyl dimethyl phosphate (International Union of

More information

Product: H12MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No )

Product: H12MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No ) February 013 Properties, Hazards and Safety Information for H1MDI* Product: H1MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No. 514-30-1) Physical and chemical data Physical state liquid Colour colourless

More information

Basic toxicology and biomaterials testing

Basic toxicology and biomaterials testing Biomateriaalitiede 2015 Basic toxicology and biomaterials testing Matti Viluksela University of Eastern Finland Department of Environmental Science and National Institute for Health and Welfare Chemicals

More information

Environmental Risk Assessment Toxicity Assessment

Environmental Risk Assessment Toxicity Assessment Environmental Risk Assessment Toxicity Assessment UT Evening School Course Spring Semester 2000 Class #07 on February 29, 2000 Environmental Engineering EV595 Martin Clauberg, Ph.D. 1 Outline of discussion

More information

Guidance on information requirements and Chemical Safety Assessment. Chapter R.7a: Endpoint specific guidance

Guidance on information requirements and Chemical Safety Assessment. Chapter R.7a: Endpoint specific guidance DRAFT Chapter R.a: Endpoint specific guidance PUBLIC: Draft Version x.0 xxxx 0 G U I D A N C E Guidance on information requirements and Chemical Safety Assessment Chapter R.a: Endpoint specific guidance

More information

Evaluation & Reporting of Data: How to provide a (robust) study summary

Evaluation & Reporting of Data: How to provide a (robust) study summary Evaluation & Reporting of Data: How to provide a (robust) study summary Webinar on Information requirements 30 November 2009 Evaluation of all available information Step 1: Evaluation of the data quality

More information

Hydrated dolomitic lime

Hydrated dolomitic lime Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products Evaluation of active substances Assessment Report Hydrated dolomitic lime Product Type 3 (Veterinary

More information

Survey results - Analysis of higher tier studies submitted without testing proposals

Survey results - Analysis of higher tier studies submitted without testing proposals Survey results - Analysis of higher tier studies submitted without testing proposals Submission of higher tier studies on vertebrate animals for REACH registration without a regulatory decision on testing

More information

Risk Assessment Report on. Bis(hydroxylammonium)sulfate. CAS No.: EINECS no.:

Risk Assessment Report on. Bis(hydroxylammonium)sulfate. CAS No.: EINECS no.: Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on Bis(hydroxylammonium)sulfate CAS No.: 10039-54-0 EINECS no.: 233-118-8 The SCHER adopted this opinion at its 21 st

More information

Quantitative Risk Assessment: An Overview and Discussion of Emerging Issues. Anne-Marie Nicol, PhD

Quantitative Risk Assessment: An Overview and Discussion of Emerging Issues. Anne-Marie Nicol, PhD Quantitative Risk Assessment: An Overview and Discussion of Emerging Issues Anne-Marie Nicol, PhD Today s talk Broader overview of Risk Assessment process (at the US EPA) Explanation of the 4 step formal

More information

CHARACTERIZING THE IMPACTS OF UNCERTAINTY AND SCIENTIFIC JUDGMENT IN EXPOSURE LIMIT DEVELOPMENT

CHARACTERIZING THE IMPACTS OF UNCERTAINTY AND SCIENTIFIC JUDGMENT IN EXPOSURE LIMIT DEVELOPMENT CHARACTERIZING THE IMPACTS OF UNCERTAINTY AND SCIENTIFIC JUDGMENT IN EXPOSURE LIMIT DEVELOPMENT Andrew Maier, Ph.D., CIH, DABT TERA Robert Sussman, Ph.D., DABT SafeBridge Consultants, Inc. Bruce Naumann,

More information

Human Health Classification: General Considerations and Overview

Human Health Classification: General Considerations and Overview Human Health Classification: General Considerations and Overview 1 Key considerations for GHS Classifications Focuses on Self Classification by industry Identify Physical State e.g., metal salt, oxide,

More information

SILICA, CRYSTALLINE (RESPIRABLE DUST)

SILICA, CRYSTALLINE (RESPIRABLE DUST) SILICA, CRYSTALLINE (RESPIRABLE DUST) CAS number: Cristobalite 14464-46-1 Quartz 14808-60-7 Tridymite 15468-32-3 Tripoli 1317-95-9 Synonyms: Chemical formula: α quartz, crystallized silicon dioxide, silica,

More information

Chapter 6 Physical and chemical quality of drinking water

Chapter 6 Physical and chemical quality of drinking water Chapter 6 Physical and chemical quality of drinking water Chapter 6 Physical and Chemical Quality of Drinking Water Chapter 6 Chapter 6 Physical and chemical quality of drinking water 6.1 Introduction

More information

Justification for the selection of a candidate CoRAP substance

Justification for the selection of a candidate CoRAP substance Justification for the selection of a candidate CoRAP substance Substance Name (Public Name): Chemical Group: Aluminium sulphate Inorganic mono-constituent EC Number: 233-135-0 CAS Number: 10043-01-3 Submitted

More information

Didecyldimethylammonium Carbonate / Bicarbonate (DDACarbonate) Product-type 08 (Wood Preservative)

Didecyldimethylammonium Carbonate / Bicarbonate (DDACarbonate) Product-type 08 (Wood Preservative) Directive 98/8/EC concerning the placing biocidal products on the market Inclusion of active substances in Annex I to Directive 98/8/EC Assessment Report Didecyldimethylammonium Carbonate / Bicarbonate

More information

HEALTH CONSULTATION. Tom Lea Park EL PASO COUNTY METAL SURVEY EL PASO, EL PASO COUNTY, TEXAS EPA FACILITY ID: TX

HEALTH CONSULTATION. Tom Lea Park EL PASO COUNTY METAL SURVEY EL PASO, EL PASO COUNTY, TEXAS EPA FACILITY ID: TX HEALTH CONSULTATION Tom Lea Park EL PASO COUNTY METAL SURVEY EL PASO, EL PASO COUNTY, TEXAS EPA FACILITY ID: TX0000605388 September 6, 2002 Prepared by: The Texas Department of Health Under a Cooperative

More information

The effect of REACH implementation on genotoxicity and carcinogenicity testing Jan van Benthem

The effect of REACH implementation on genotoxicity and carcinogenicity testing Jan van Benthem The effect of REACH implementation on genotoxicity and carcinogenicity testing Jan van Benthem National Institute for Public Health and the Environment Laboratory for Health Protection Research Bilthoven

More information

Benzothiazole-2-thiol (2-MBT)

Benzothiazole-2-thiol (2-MBT) SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Benzothiazole-2-thiol (2-MBT) EC No 205-736-8 CAS No 149-30-4 Evaluating Member State(s): Germany Dated: 17 March 2014 Evaluating

More information

Explanatory note. On an opinion proposing harmonised classification and labelling at EU level of. glyphosate (ISO); N-(phosphonomethyl)glycine

Explanatory note. On an opinion proposing harmonised classification and labelling at EU level of. glyphosate (ISO); N-(phosphonomethyl)glycine Explanatory note On an opinion proposing harmonised classification and labelling at EU level of glyphosate (ISO); N-(phosphonomethyl)glycine EC Number: 213-997-4 CAS Number: 1071-83-6 This note has been

More information

Pizza Pan Case Study

Pizza Pan Case Study Session 4 Case Study of Risk Assessment and Management Pizza Pan Case Study Fernanda Takata The Dow Chemical Company, Product Stewardship and Regulatory Specialist 16 March, May, 2013 2011 Taipei Chile

More information

ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5

ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5 European Medicines Agency October 2008 EMEA/CHMP/ICH/383/1995 ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON DOSE SELECTION FOR CARCINOGENICITY

More information

Benzene exposure and cancer. Scientific evidence and regulatory development Highlights from yesterday s expert seminar

Benzene exposure and cancer. Scientific evidence and regulatory development Highlights from yesterday s expert seminar Benzene exposure and cancer. Scientific evidence and regulatory development Highlights from yesterday s expert seminar Karl-Christian Nordby MD, PhD, Dept of Occupational Medicine and Epidemiology, STAMI

More information

FÜR RISIKOBEWERTUNG BUNDESINSTITUT

FÜR RISIKOBEWERTUNG BUNDESINSTITUT BUNDESINSTITUT FÜR RISIKOBEWERTUNG Legal and Practical Aspects of the Cut-off Criteria for Reproductive Toxic and Endocrine Disrupting Effects for Approval and Classification of Pesticides in Europe Roland

More information

Pesticide Risk in Perspective

Pesticide Risk in Perspective Pesticide Risk in Perspective Bob Krieger, Ph. D. Personal Chemical Exposure Program Department of Entomology University of California, Riverside CA 92521 951 827 3724 bob.krieger@ucr.edu Toxicology Scientific

More information

3-MCPD and glycidol and their esters

3-MCPD and glycidol and their esters Toxicological Risk Assessment of 3-monochloropropane-1,2-diol (3-MCPD) Esters and Glycidol Esters: Is there a Need for Concern? Ivonne M.C.M. Rietjens Division of Toxicology Wageningen University ivonne.rietjens@wur.nl

More information

APPLICATION FOR AUTHORISATION: DNEL SETTING FOR REPROTOXIC PROPERTIES OF DIGLYME

APPLICATION FOR AUTHORISATION: DNEL SETTING FOR REPROTOXIC PROPERTIES OF DIGLYME 1 (17) Helsinki, 05 June 2015 RAC/33/2015/08 rev 1 Final APPLICATION FOR AUTHORISATION: DNEL SETTING FOR REPROTOXIC PROPERTIES OF DIGLYME Background At the 22 nd meeting of the Committee for Risk Assessment

More information

Biocidal Products Committee (BPC)

Biocidal Products Committee (BPC) Biocidal Products Committee (BPC) Opinion on the application for approval of the active substance: Salicylic acid Product type: 2 ECHA/BPC/187/2018 6 March 2018 Annankatu 18, P.O. Box 400, FI-00121 Helsinki,

More information

Justification Document for the Selection of a CoRAP Substance

Justification Document for the Selection of a CoRAP Substance Justification Document for the Selection of a CoRAP Substance Substance Name (public name): Sodium hydroxymethanesulphinate EC Number: 205-739-4 CAS Number: 149-44-0 Authority: NL MSCA Date: 22/03/2016

More information

Impact of genotoxicity in risk assessment of pesticides, their metabolites and degradates

Impact of genotoxicity in risk assessment of pesticides, their metabolites and degradates Impact of genotoxicity in risk assessment of pesticides, their metabolites and degradates Claudia Bolognesi Environmental Carcinogenesis Unit, National Institute for Cancer research, Genova New Pesticide

More information

Dithianon DITHIANON (180)

Dithianon DITHIANON (180) Dithianon 201 5.11 DITHIANON (180) TOXICOLOGY Dithianon (C 14 H 4 N 2 O 2 S 2 ) is the International Organization for Standardization (ISO) approved name for 5,10-dihydro-5,10-dioxonaphtho[2,3-b]-1,4-dithiine-2,3-dicarbonitrile

More information

Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Health and environmental hazards Classification criteria for substances and mixtures Working definitions Substance: Chemical

More information

1,1 - iminodipropan-2-ol

1,1 - iminodipropan-2-ol SUBSTANCE EVALUATION REPORT Background document for the purpose of substance evaluation under REACH for 1,1 - iminodipropan-2-ol EC No 203-820-9 CAS No 110-97-4 Evaluating Member State(s): Czech Republic

More information

Questions and Answers on Candidates for Substitution

Questions and Answers on Candidates for Substitution Questions and Answers on Candidates for Substitution Rev. 1, January 2015 Background The European Commission is required by Regulation (EC) No 1107/2009 ( the Regulation ) to establish a list of substances

More information

Toxicology. Toxicity. Human Health Concerns. Health Effects of Hazardous Materials

Toxicology. Toxicity. Human Health Concerns. Health Effects of Hazardous Materials Human Health Concerns Health Effects of Hazardous Materials Toxicology Study of the nature, effects, and detection of poisons in organisms Humans are obvious focal point Other species and ecosystem function

More information

Biocidal Products Committee (BPC)

Biocidal Products Committee (BPC) Biocidal Products Committee (BPC) Opinion on the application for approval of the active substance: Hydrated lime Product type: 2 ECHA/BPC/100/2016 Adopted 14 April 2016 Annankatu 18, P.O. Box 400, FI-00121

More information

Justification for the selection of a candidate CoRAP substance

Justification for the selection of a candidate CoRAP substance Justification for the selection of a candidate CoRAP substance Substance Name (Public name): 2, 2, 2 -nitrilotriethanol EC Number: 203-049-8 CAS Number: 102-71-6 Submitted by: Bureau for Chemical Substances,

More information

Development of NJ Human Health-based Criteria and Standards

Development of NJ Human Health-based Criteria and Standards Development of NJ Human Health-based Criteria and Standards Gloria Post NJDEP Office of Science Presented to: Public Health Standing Committee October 18, 2010 Human Health-based Criteria and Standards

More information

Guidance on information requirements and chemical safety assessment R.8: Characterisation of dose [concentration] - response for human health

Guidance on information requirements and chemical safety assessment R.8: Characterisation of dose [concentration] - response for human health Chapter R.: Characterisation of dose [concentration]-response for human Draft (Public) Version.0 November 0 Guidance on information requirements and chemical safety assessment R.: Characterisation of dose

More information

OELVs from health hazard Control banding

OELVs from health hazard Control banding OELVs from health hazard Control banding Shifting from R-phrases to H3##-statements. Theo Scheffers, Geert Wieling DOHSBASE v.o.f. 2 types of workplace exposure limits in the EU REACH substance liability:

More information

Dermal Occupational Exposure Limits. Their use in risk assessment

Dermal Occupational Exposure Limits. Their use in risk assessment Dermal Occupational Exposure Limits Their use in risk assessment Contents 1. Risk assessment for dermal exposure 2. Dermal Occupational Exposure Limit (DOEL) 3. REACH 4. SCOEL 5. ECETOC 6. Summary Risk

More information

Safety Data Sheet according to 1907/2006/EC (REACH), 1272/2008/EC (CLP), and OSHA GHS

Safety Data Sheet according to 1907/2006/EC (REACH), 1272/2008/EC (CLP), and OSHA GHS Page 1/12 (Con d on page 2) Page 2/12 (Con d rom page 1) (Con d on page 3) Page 3/12 Dangerous components: CAS: 67-63-0 EINECS: 200-661-7 Index number: 603-117-00-0 CAS: 85665-42-5 EINECS: 288-131-1 (Con

More information

N-Methylneodecanamide (MNDA)

N-Methylneodecanamide (MNDA) United States Prevention, Pesticides EPA-730-F-99-008 Environmental Protection And Toxic Substances July 1999 Agency (7505C) New Pesticide Fact Sheet Description of the Chemical N-Methylneodecanamide (MNDA)

More information

ENV 455 Hazardous Waste Management

ENV 455 Hazardous Waste Management Risk Assessment Basic Information ENV 455 Hazardous Waste Management Environmental Risk Assessment Özgür ZEYDAN (Phd.) http://cevre.beun.edu.tr/zeydan/ Hazard: a potential source of harm to a worker. Risk:

More information